pentobarbital will lessen the extent or result of roflumilast by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not recommended; robust cytochrome P450 enzyme inducers lessen systemic publicity to roflumilast and should decrease the therapeutic efficiencyDependancy Useful resource aims to deliver only ess